单位：[1]Capital Med Univ, Dept Clin Pharmacol, Beijing Luhe Hosp Affiliated, Beijing, Peoples R China[2]China Japan Friendship Hosp, Dept Hlth Care 2, Beijing 100029, Peoples R China[3]China Japan Friendship Hosp, Dept Hematol, Beijing, Peoples R China
Acute promyelocytic leukemia (APL), more common in young and middle-aged people, is a unique subtype of acute myeloid leukemia. Recently, the experience in the treatment of elderly APL is limited. This report described the first case of APL in a patient older than 90 years in China. With the stealthy onset and no typical symptoms, the diagnosis was made timely based on close detection of laboratory examination. After a comprehensive evaluation of the patient's condition, the patient received half-dose arsenic trioxide (ATO) alone. The patient tolerated this dose well and achieved molecular complete remission. This report also provides clinical experience for the treatment of elderly APL. Copyright (C) 2022, Taiwan Society of Geriatric Emergency & Critical Care Medicine.
第一作者单位：[1]Capital Med Univ, Dept Clin Pharmacol, Beijing Luhe Hosp Affiliated, Beijing, Peoples R China
通讯作者：
通讯机构：[2]China Japan Friendship Hosp, Dept Hlth Care 2, Beijing 100029, Peoples R China[*1]The Second Department of Health Care, China-Japan Friendship Hospital, Beijing 100029, China.
推荐引用方式(GB/T 7714)：
Xie Zongyan,Wang Yunyun,Wang Xi,et al.Treatment of Acute Promyelocytic Leukemia in a 94-Year-Old Male Patient: A Case Report[J].INTERNATIONAL JOURNAL of GERONTOLOGY.2022,16(2):150-152.doi:10.6890/IJGE.202204_16(2).0015.
APA：
Xie, Zongyan,Wang, Yunyun,Wang, Xi,Wang, Min&Qiao, Wei.(2022).Treatment of Acute Promyelocytic Leukemia in a 94-Year-Old Male Patient: A Case Report.INTERNATIONAL JOURNAL of GERONTOLOGY,16,(2)
MLA：
Xie, Zongyan,et al."Treatment of Acute Promyelocytic Leukemia in a 94-Year-Old Male Patient: A Case Report".INTERNATIONAL JOURNAL of GERONTOLOGY 16..2(2022):150-152
